Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030

Healthcare Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030

Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development

INDUSTRY
Healthcare

RELEASE DATE
08-Nov-2024
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
KAE6-01-00-00-00
SKU
HC_2024_1121
Yes
SHARE

$4,950.00

Special Price $4,207.50 save 15 %

In stock
SKU
HC_2024_1121

Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030
Published on: 08-Nov-2024 | SKU: HC_2024_1121

Need more details?

$4,950.00

$4,207.50 save 15 %

DownloadLink
Need more details?

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification.

This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.

Scope of Analysis

Segmentation

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Clinical Next-generation Sequencing Industry

Competitive Environment

Key Competitors

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Considerations

Revenue Forecast

Revenue Forecast by Product

Revenue Forecast by Workflow

Revenue Forecast by Application

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Pricing Trends and Forecast Analysis

Revenue Share

Revenue Share Analysis

Competitive Players

Competitive Players (continued)

Company Informatics Solutions for Applications

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine

Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine (continued)

Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer

Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer (continued)

Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research

Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research (continued)

Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA

Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA (continued)

Benefits and Impacts of Growth Opportunities

Next Steps

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • Clinical NGS: Growth Metrics, Global, 2024
  • Clinical NGS: Growth Drivers, Global, 2025-2030
  • Clinical NGS: Growth Restraints, Global, 2025-2030
  • Clinical NGS: Revenue Forecast, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Product, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Workflow, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Application, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Region, Global, 2024-2030
  • Clinical NGS: Revenue Share of Top 4 Participants, Global, 2024
  • Instruments: Growth Metrics, Global, 2024
  • Instruments: Revenue Forecast, Global, 2024-2030
  • Instruments: Revenue Forecast by Region, Global, 2024-2030
  • Workflow Solutions: Growth Metrics, Global, 2024
  • Workflow Solutions: Revenue Forecast, Global, 2024-2030
  • Workflow Solutions: Revenue Forecast by Region, Global, 2024-2030
  • Services: Growth Metrics, Global, 2024
  • Services: Revenue Forecast, Global, 2024-2030
  • Services: Revenue Forecast by Region, Global, 2024-2030
  • Informatics: Growth Metrics, Global, 2024
  • Informatics: Revenue Forecast, Global, 2024-2030
  • Informatics: Revenue Forecast by Region, Global, 2024-2030

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

04 Aug 2026   |   Global   |   Market Research

Global Capnography Devices Market, Forecast to 2031

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...

31 Jul 2026   |   Global   |   Market Research

Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward s...

30 Jul 2026   |   Global   |   Frost Radar

Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...

30 Jul 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Wearables and Drug Delivery Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.

The issue features advanced medical devices such as non-invasive bimoda...

24 Jul 2026   |   Global   |   Frost Radar

Frost Radar™: Neuromodulation Devices, 2026

Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life, gaining momentum as a cost-efficient, long-term treatment for neurological and nerve-related disorders. The prevalence of neurological disorders and nerve inju...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification. This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.
More Information
Deliverable Type Market Research
Author Lucila Martin
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Clinical Ngs Market
Keyword 2 Next-Gen Sequencing Trends
Keyword 3 Precision Medicine Innovations
List of Charts and Figures Clinical NGS: Growth Metrics, Global, 2024~ Clinical NGS: Growth Drivers, Global, 2025-2030~ Clinical NGS: Growth Restraints, Global, 2025-2030~ Clinical NGS: Revenue Forecast, Global, 2024-2030~ Clinical NGS: Revenue Forecast by Product, Global, 2024-2030~ Clinical NGS: Revenue Forecast by Workflow, Global, 2024-2030~ Clinical NGS: Revenue Forecast by Application, Global, 2024-2030~ Clinical NGS: Revenue Forecast by Region, Global, 2024-2030~ Clinical NGS: Revenue Share of Top 4 Participants, Global, 2024~ Instruments: Growth Metrics, Global, 2024~ Instruments: Revenue Forecast, Global, 2024-2030~ Instruments: Revenue Forecast by Region, Global, 2024-2030~ Workflow Solutions: Growth Metrics, Global, 2024~ Workflow Solutions: Revenue Forecast, Global, 2024-2030~ Workflow Solutions: Revenue Forecast by Region, Global, 2024-2030~ Services: Growth Metrics, Global, 2024~ Services: Revenue Forecast, Global, 2024-2030~ Services: Revenue Forecast by Region, Global, 2024-2030~ Informatics: Growth Metrics, Global, 2024~ Informatics: Revenue Forecast, Global, 2024-2030~ Informatics: Revenue Forecast by Region, Global, 2024-2030~
Podcast No
Predecessor K555-01-00-00-00
WIP Number KAE6-01-00-00-00